Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The chair of the Somerset Association of Primary Head teachers has raised concerns about plans to force failing primary schools to convert to academy status. The county has seven schools assessed as failing. Many smaller schools nationally are concerned about the additional responsibilities they would be taking on especially when they currently obtain their support services through the local authority.
It is important for primary schools to consider all available options and for smaller schools converting as part of a group may be the most beneficial way to proceed. Schools can convert as part of formalised multi academy trusts or may come together in looser collaborative arrangements. Primary schools deemed failing should consider actively seeking a suitably approved DfE sponsor, of which there are now nearly 250.
Converting as part of a group provides primary schools with commensurate benefits in purchasing services and sharing resources to achieve economies of scale. Primary schools should take the opportunity to collaborate to focus on improving school standards.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up